Teladoc Health announces acquisition of France-based MedecinDirect
Category: #health  By Pankaj Singh  Date: 2019-03-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Teladoc Health announces acquisition of France-based MedecinDirect
  • The deal is expected to be closed in first half of this year
     
  • Financial terms of the deal were not disclosed yet

Virtual care provider Teladoc Health has announced that it has acquired France-based telemedicine provider MédecinDirect to expand its international business. Teladoc will combine its virtual care services with strong and established local medical operations of MédecinDirect and hopes to benefit more people across France by providing virtual care services, as Teladoc is already stable to capitalize on favorable market conditions.

This deal is expected to be closed in first half of this year, but financial terms of the deal were not disclosed yet. It is stated that acquisition will be immaterial to the financial results of Teladoc Health.

MédecinDirect will become the French country unit of Teladoc Health with existing operations in United Kingdom, Australia, Portugal, Chile, Brazil, Spain, Hungary, China and Canada.

As reported by Teladoc, France has increasing demands for accessible high-quality healthcare services like other countries around the world. Consumers are being more aware about virtual care and the recent regulatory changes have been positive about virtual care reimbursement. This has ripened the market to adopt virtual care. MédecinDirect has well-established client base in France and partnership with almost half of the 30 private medical insurers (PMIs) and more than 40 leading insurance companies.

Francois Lescure, CEO and co-founder, MédecinDirect, reportedly stated that they have enjoyed success in virtual care market and after acquisition with Teladoc Health they are expecting to reach more people and offer more care needs to improve healthcare across the country. With Teladoc Health, MédecinDirect has plans of transforming healthcare accessibility, Lescure further added.

Carlos Nueno, President of Teladoc Health International, noted that the company has a vision of global expansion and with focus on this, Teladoc will become leader in France’s healthcare market and will immediately impact delivery of healthcare in France. He added that Teladoc will bring full suite of virtual care services with support of strong base achieved by MédecinDirect, to multinational clients who have been willing to expand.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Dressbarn confirms 53 stores to close in August as wind down nears
Dressbarn confirms 53 stores to close in August as wind down nears
By Pankaj Singh

Ascena shares have been down by more than 75% this year and are trading at below $1 Ascena Retail Group, an American retailer for women’s clothing, recently announced that it is going to shut down 53 locations of Dressbarn by the end of August...

Japan introduces working group to examine impact of Facebook’s Libra
Japan introduces working group to examine impact of Facebook’s Libra
By Pankaj Singh

Japan is looking to garner greater support due to the wide range of policies which can be affected by digital currencies. Japanese authorities have reportedly established a working group to discuss the impact Libra digital coin proposed by Facebook ...

Ligand Pharma announces positive results from trial of CE-Iohexol
Ligand Pharma announces positive results from trial of CE-Iohexol
By Pankaj Singh

Ligand Pharmaceuticals, a US-based biopharmaceutical company recently announced positive top line results from clinical trial of its internal CE (Captisol-enabled) Iohexol program. The study attained primary endpoint indicating pharmacokinetic b...